Semaglutide reduces excess body fat in people with obesity
In adults with obesity or overweight, weekly treatment with the glucagon-like peptide 1 (GLP1) receptor agonist semaglutide leads to reduced
Read more
In adults with obesity or overweight, weekly treatment with the glucagon-like peptide 1 (GLP1) receptor agonist semaglutide leads to reduced
Read moreAn existing service in the North West of England called Community Connectors, which enables adults to access social activities within
Read moreScientists have found that adding cognitive behavioural therapy (CBT) to standardised medical care gives patients with dissociative seizures longer periods
Read moreThe innovative treatment model, Improving Access to Psychological Therapies (IAPT), and its Norwegian adaptation, Prompt Mental Health Care (PMHC), have
Read moreRutgers researchers have found that a Texas strategy to reduce anti-psychotic medication for children can serve as a model for
Read moreOne challenge facing researchers who study brain diseases is that for understandable reasons it is difficult to obtain human brain
Read moreOverweight women in their 50s who lose 20lbs are 26% less likely to get breast cancer – even if they
Read moreAtrial fibrillation is one of the most common complications following heart surgery, affecting one in three patients. This adverse side-effect,
Read more(HealthDay)—Compared with placebo, oral semaglutide monotherapy is associated with superior and clinically relevant improvements in glycated hemoglobin (HbA1c) and weight
Read moreParkinson’s disease often begins with small tremors. Over time symptoms worsen. Tremors become shakes and stiffness takes the body hostage.
Read more